Literature DB >> 30257379

Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.

Shivani Jaiswal1, Rati Kailash Prasad Tripathi2, Senthil Raja Ayyannan3.   

Abstract

Fatty acid amide hydrolase (FAAH) represents a potential therapeutic target for number of peripheral and nervous system related disorders including neuropathic pain and neuroinflammation. A library of N-(2,4-dichlorobenzoyl) isatin Schiff bases 7a-7l and 8a-8c were designed using the contemporary scaffold-hopping approach, synthesized and investigated for their ability to inhibit human FAAH enzyme using fluorescence based Cayman assay kit. The synthesized compounds inhibited FAAH with IC50 values in the range from 1.49 to 12,858 μM. Compound, 3-(1H-benzoimidazol-2-ylimino)-1-(2,4-dichlorobenzoyl)indolin-2-one (8c) showed strong inhibition against FAAH with IC50 of 1.49 ± 0.03 μM. SAR studies revealed various structural aspects important for the potency of these analogs. In particular, our findings suggested the requirement of hydrophobic aryl/heteroaryl moiety at C-3 position of isatin for optimum rigidity and steric hindrance to the scaffold. Additionally, molecular docking studies supported the experimental results revealing that compound 8c well-occupied the enzymatic cleft with optimal binding orientation and interactions within the active site of FAAH which resulted in reduced susceptibility of compound to nucleophilic attack and prevented it from leaving the active site, thereby increasing the inhibition. Also, compound 8c presented potent antidepressant and anxiolytic properties without any neurotoxicity. In silico molecular properties and ADMET descriptors calculations related the lead FAAH inhibitor 8c presented the satisfactory drug-like characteristics and ADMET properties and thus considered for further optimization. To the best of our knowledge this is the first report on the FAAH inhibitory properties of isatin-based analogs, revealing that both indoline skeleton and heteroaryl substitution at C-3 can modulate the activity of FAAH enzyme. In conclusion, the present study provided a better understanding of the molecular fragments requisite for maintaining and/or improving FAAH inhibition activity.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fatty acid amide hydrolase; Isatin; Molecular docking; Scaffold hopping; Schiff base

Mesh:

Substances:

Year:  2018        PMID: 30257379     DOI: 10.1016/j.biopha.2018.08.125

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Phenolic compounds from nutmeg (Myristica fragrans Houtt.) inhibit the endocannabinoid-modulating enzyme fatty acid amide hydrolase.

Authors:  Abir T El-Alfy; Ehab A Abourashed; Christina Patel; Nunmoula Mazhari; HeaRe An; Andrew Jeon
Journal:  J Pharm Pharmacol       Date:  2019-10-08       Impact factor: 3.765

2.  Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.

Authors:  Ashraf S Hassan; Gaber O Moustafa; Hanem M Awad; Eman S Nossier; Mohamed F Mady
Journal:  ACS Omega       Date:  2021-04-29

3.  Kaempferol Facilitated Extinction Learning in Contextual Fear Conditioned Rats via Inhibition of Fatty-Acid Amide Hydrolase.

Authors:  Hammad Ahmad; Khalid Rauf; Wahid Zada; Margaret McCarthy; Ghulam Abbas; Fareeha Anwar; Abdul Jabbar Shah
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

4.  Fatty acid amide hydrolase inhibition and N-arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants.

Authors:  Wahid Zada; Jonathan W VanRyzin; Miguel Perez-Pouchoulen; Samantha L Baglot; Matthew N Hill; Ghulam Abbas; Sarah M Clark; Umer Rashid; Margaret M McCarthy; Abdul Mannan
Journal:  Pharmacol Res Perspect       Date:  2022-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.